Saniona Chairman J. Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market
PRESS RELEASE
December2, 2021
Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announcedthat the Chairman and the CEO, as well as additional members of the Board of Directors and executive management team, have purchased 82,000 shares of the company in the open market for a total value of approximately SEK 861,182.
Saniona Chairman of the Board J. Donald deBethizy bought 20,000 shares in the company for a total investment of SEK 228,548. President and CEO Rami Levin bought 10,000 shares in the company for a total investment of SEK 100,045. In addition, a total of 52,000 shares were acquired by the other members of Saniona's Board of Directors and executive management team. All transactions have been made in the open market through broker-assisted trades during the period from 19 November 2021 to 2 December 2021.
For more information, please contact
Trista Morrison, Chief Communications Officer, Saniona. Office: + 1 (781) 810-9227. Email: trista.morrison@saniona.com
The information was submitted for publication, through the agency of the contact person set out above, at 22:45 CET on 2December 2021.
About Saniona
Saniona is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for patients suffering from rare diseases for which there are a lack of available treatment options. The company’s lead product candidate, Tesomet, is in mid-stage clinical trials for hypothalamic obesity and Prader-Willi syndrome, serious rare disorders characterized by severe weight gain, disturbances of metabolic functions and uncontrollable hunger. Saniona has developed a proprietary ion channel drug discovery engine anchored by IONBASE™, a database of more than 130,000 compounds, of which more than 20,000 are Saniona’s proprietary ion channel modulators. Through its ion channel expertise, Saniona is advancing two wholly-owned ion channel modulators, SAN711 and SAN903. SAN711 is in a Phase 1 clinical trial and may be applicable in the treatment of rare neuropathic disorders, and SAN903 is in preclinical development for rare inflammatory, fibrotic and hematological disorders. Led by an experienced scientific and operational team, Saniona has an established research organization in the Copenhagen area, Denmark, and a corporate office in the Boston, Massachusetts area, U.S. The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at http://www.saniona.com.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Major shareholder announcement18.4.2024 17:17:13 CEST | Press release
Bang & Olufsen A/S has pursuant to the Danish Capital Markets Act § 38 received a major shareholder announcement from New Sparkle Roll International Group Limited which states that New Sparkle Roll International Group Limited’s, through Sparkle Roll (Denmark) Limited, indirect holding of shares and voting rights as per 12 April 2024 is below 10 per cent of the total number of shares and voting rights in Bang & Olufsen A/S. As per 12 April 2024, New Sparkle Roll International Group Limited indirectly holds 12,241,123 shares and voting rights in Bang & Olufsen A/S corresponding to 9.97 per cent of the total number of shares and voting rights. For further information, please contact: Head of Investor Relations, Cristina Rønde Hefting, phone: +45 4153 7303 Attachment BO_2312_Major shareholder announcement Sparkle Roll UK
Storaktionærmeddelelse18.4.2024 17:17:13 CEST | pressemeddelelse
Bang & Olufsen A/S har i henhold til kapitalmarkedslovens § 38 modtaget en storaktionærmeddelelse fra New Sparkle Roll International Group Limited, hvoraf det fremgår, at New Sparkle Roll International Group Limited’s indirekte besiddelse, gennem Sparkle Roll (Denmark) Limited, af aktier og stemmerettigheder per den 12. april er faldet til under 10 procent af de samlede antal aktier og stemmerettigheder i Bang & Olufsen A/S. New Sparkle Roll International Group Limited besidder per 12. april 2024 indirekte 12.241.123 aktier og stemmerettigheder i Bang & Olufsen A/S svarede til 9,97 procent af det samlede antal aktier og antal stemmer. For mere information, kontakt venligst: Head of Investor Relations, Cristina Rønde Hefting, phone: +45 4153 7303 Vedhæftet fil BO_2312_Storaktionærmeddelelse - Sparkle Roll DK
A new prize for the Monaco Energy Boat Challenge to encourage sustainable yachting18.4.2024 17:14:02 CEST | Press release
TURIN, Italy, April 18, 2024 (GLOBE NEWSWIRE) -- A new prize for the Monaco Energy Boat Challenge to reward innovative university projects. The Prince Albert II of Monaco Foundation, an active Monaco Energy Boat Challenge partner, is adding another dimension to the partnership in launching the Prince Albert II of Monaco Foundation Sustainable Yachting Technology Award. The contest is open to universities anywhere in the world and on 6th July will reward the best technological solution that is applicable to yachting in terms of energy efficiency and/or carbon reduction. "We are pleased to initiate this prize to help finance the development of a university’s department with a grant of 25,000 euros. We hope to encourage the winner to go further with its applied research and who knows maybe help those prototypes progress towards a more industrial solution", explains Olivier Wenden, Vice-President of the Prince Albert II of Monaco Foundation. Once the grant has been awarded, the winner will
Resultat af den ordinære generalforsamling 202418.4.2024 17:07:01 CEST | pressemeddelelse
SELSKABSMEDDELELSE Odense, 18. april 2024 Selskabsmeddelelse nr. 49 – 18.04.24 Resultat af den ordinære generalforsamling 2024 Danish Aerospace Company A/S CVR nr.: 12 42 42 48 Torsdag den 18. april 2024 afholdtes ordinær generalforsamling i Danish Aerospace Company A/S. Dagsordenen var følgende: 1. Valg af dirigent 2. Bestyrelsens beretning om selskabets virksomhed i det forgangne regnskabsår 3. Forelæggelse af årsrapport med revisionspåtegning til godkendelse 4. Beslutning om anvendelse af overskud eller dækning af underskud i henhold til den godkendte årsrapport. 5. Bemyndigelse til at forhøje selskabskapitalen 6. Bemyndigelse til at udstede aktietegningsretter 7. Valg af medlemmer til bestyrelsen, herunder formand og næstformand. 1.1 Valg af formand 1.2 Valg af næstformand 1.3 Valg af øvrige medlemmer af bestyrelsen 8. Valg af revisor 9. Forslag fra bestyrelsen eller aktionærerne 9.1 Ny §3.5 i vedtægterne om mulighed for at afholde generalforsamlinger som delvis eller fuld elektron
Results of annual general meeting 202418.4.2024 17:07:01 CEST | Press release
COMPANY ANNOUNCEMENT Odense, April 18th, 2024 Company Announcement no. 49 – 18.04.2024 Results of annual general meeting 2024 Danish Aerospace Company A/S CVR no.: 12 42 42 48 On Thursday April 18th, 2024, the annual general meeting of Danish Aerospace Company A/S was held. The agenda was as follows: 1. Election of chairperson for the Annual Meeting. 2. The Board of Directors’ report on the company’s activities in the past financial year. 3. Presentation of the 2023 Annual Report including auditor’s report for approval. 4. Decision on use of profit or coverage of deficit in regard to the approved annual report. 5. Authorization to increase the company’s share capital. 6. Authorization to issue warrants. 7. Election of members for the Board of Directors, including chairman and deputy chairman. 1.1 Election of chairman. 1.2 Election of deputy chairman. 1.3 Election of remaining members of the board. 8. Election of auditor. 9. Proposals from the Board of Directors or shareholders. 9.1 New